bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.03.31.646504

Global transcriptional reprogramming by cytomegalovirus infection suppresses antigen presentation while enhancing migration machinery in murine dendritic cells.

Abstract

Dendritic cells (DCs) serve dual roles in cytomegalovirus infection: orchestrating antiviral immunity and acting as vehicles for viral dissemination. DC-dependent systemic spread of mouse cytomegalovirus (MCMV) is dependent on expression of a viral G protein-coupled receptor (GPCR) homolog, encoded by M33. We performed global transcriptional profiling of murine DCs infected with either wild-type mouse MCMV or a M33 mutant harbouring a single point mutation (R131Q; denoted M33NQY), which ablates constitutive G protein-dependent signalling. RNA-seq analysis revealed that MCMV induces substantial transcriptional reprogramming, with over 2,400 significantly altered genes affecting key immune and migration pathways. Wild-type MCMV infection resulted in 1,883 upregulated and 658 downregulated genes, while M33NQY infection showed comparable effects with 1,905 upregulated and 668 downregulated genes. Both viruses systematically downregulated the MHC class II antigen presentation machinery, with substantial suppression of H2 molecules, peptide-loading components (H2-DMa/H2-DMb1), and the class II transactivator Ciita (log2FC > -6.4). Pathway analysis revealed coordinated disruption of B cell receptor signalling, leukocyte transendothelial migration, and antigen processing and presentation. A comparison between wild-type and M33NQY-infected DCs demonstrated that while both viruses similarly impair antigen presentation, M33 signalling specifically enhances the expression of genes involved in transendothelial migration, including Spp1 (osteopontin, log2FC = 0.65), cytoskeletal components (Actg1, Actb), adhesion molecules (Icam1), and matrix interaction factors (Tnc, Plau). Network analysis identified critical hub genes, including B2m, Itgb1, Itgam, and Icam1, as key regulatory nodes connecting antigen presentation and migration pathways. This provides molecular evidence for a sophisticated viral strategy that shields MCMV from immune detection while hijacking DC migratory machinery to facilitate dissemination, with M33 serving as a specific enhancer of migration-related pathways. Impact StatementThis study provides the first comprehensive transcriptional profile of mouse cytomegalovirus (MCMV) infection in dendritic cells, revealing a sophisticated viral strategy that simultaneously suppresses antigen presentation while enhancing migration machinery. We identified that MCMV systematically downregulates the entire MHC class II pathway by targeting the master regulator Ciita, while the viral G protein-coupled receptor M33 specifically enhances genes involved in transendothelial migration, including Spp1 (osteopontin). Our network analysis identified critical hub genes connecting immune evasion and migration pathways, providing molecular evidence for how MCMV exploits dendritic cells as vehicles for dissemination while evading immune detection. These findings advance our understanding of betaherpesvirus pathogenesis and highlight potential therapeutic targets to limit viral spread.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Parry, R. H., McMillan, C. L. D., Bruce, K. L., Farrell, H. E.. 2025-04-01. Global transcriptional reprogramming by cytomegalovirus infection suppresses antigen presentation while enhancing migration machinery in murine dendritic cells.. https://doi.org/10.1101/2025.03.31.646504

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗